Related Experiment Video

Updated: Mar 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Association between selected gene polymorphisms and statin metabolism, risk of ischemic stroke and cardiovascular

Dariusz Kotlęga1, Monika Gołąb-Janowska1, Marta Masztalewicz1

  • 1Department of Neurology, Pomeranian Medical University, Szczecin, Poland.

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|May 17, 2016
PubMed

Insights

Statins are crucial for preventing cardiovascular disorders like ischemic stroke. Genetic variations influence how individuals respond to statin therapy, paving the way for personalized stroke prevention strategies.

Area of Science:

  • Pharmacogenetics
  • Cardiovascular Medicine
  • Neuroscience

Background:

  • Statins are widely prescribed for cardiovascular disease prevention, including ischemic stroke.
  • Beyond lipid-lowering, statins exhibit pleiotropic effects, such as immunomodulation.
  • Genetic factors, including single nucleotide polymorphisms (SNPs), significantly influence drug metabolism and response.

Purpose of the Study:

  • To review common genetic variants in genes related to lipid and statin metabolism.
  • To explore associations between these genetic variants and cardiovascular disorders, particularly ischemic stroke.
  • To highlight the potential for pharmacogenetics in tailoring statin therapy for stroke patients.

Main Methods:

  • Literature review of pharmacogenetic studies.
  • Analysis of single nucleotide polymorphisms (SNPs) in key genes.
  • Focus on proteins involved in lipid metabolism and statin pathways.

Main Results:

  • Identified significant SNPs in genes encoding proteins like cytochrome P450, apolipoprotein E, HMGCR, and CETP.
  • These SNPs show potential associations with cardiovascular disorders and ischemic stroke risk.
  • Data suggests genetic variability impacts statin efficacy and metabolism.

Conclusions:

  • Genetic variations in lipid and statin metabolism genes are linked to cardiovascular disorders, especially ischemic stroke.
  • Understanding these SNPs can inform personalized statin treatment approaches.
  • Pharmacogenetic insights are essential for optimizing statin therapy in stroke prevention and management.

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.5K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.2K

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
102
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
101
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
104
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
86